Abstract The use of direct oral anticoagulant in cancer patients is an emerging issue. which seems to be an alternative to low molecular weight heparin. Every year several new drugs are approved as anticancer treatment with possible drug-drug interaction with other drugs such as oral anticoagulant. We describe. https://foldlyers.shop/product-category/laptop-charger-65w/
Cabozantinib and apixaban: an hitherto unreported interaction
Internet 12 hours ago zaikiibx8u09rWeb Directory Categories
Web Directory Search
New Site Listings